Published inPrime Movers LabWhy We Invested in Gilgamesh (Again)Substantial progress on new programs and a clear path to the clinic for two lead compoundsDec 15, 2022Dec 15, 2022
Published inPrime Movers LabThe Neurotech Revolution Goes to Washington!Insights from Paradromics CEO Matt Angle on the Bioeconomy and Biomanufacturing White House SummitSep 20, 2022Sep 20, 2022
Published inPrime Movers LabWomen Make Great Scientists, Engineers, Investors, CEOs and more!A few memories and some thoughts from my recent meetings and travelsJun 27, 2022Jun 27, 2022
Published inPrime Movers LabWebinar Recap: Regenerative MedicineUnlocking the innate intelligence of the body to rebuild and repairFeb 23, 2022Feb 23, 2022
Published inPrime Movers LabPrime Movers Lab Webinar Series: Regenerative MedicineExploring leading research and development in tissue repair and organ regenerationFeb 9, 2022Feb 9, 2022
Published inPrime Movers LabWhat to Watch — Life Sciences 2022What surprises might this year hold?Jan 18, 20221Jan 18, 20221
Published inPrime Movers LabWhy We Invested in IridiaHarnessing nature’s perfect data storage systemDec 14, 2021Dec 14, 2021
Published inPrime Movers LabWhy We Invested in CognixionUnlocking the cognitive capacity of millions of individualsNov 16, 2021Nov 16, 2021
Published inPrime Movers LabWebinar Recap: The Emerging Promise of NeuromodulationInsights from a stimulating discussion with experts in the fieldNov 5, 2021Nov 5, 2021
Published inPrime Movers LabPrime Movers Lab Webinar Series: The Emerging Promise of NeuromodulationTherapies for the Body and Brain without DrugsOct 27, 20211Oct 27, 20211